A new Mercer report predicts there will be a national surplus of about 30,000 nurses by 2028. Though an overall surplus is projected nationally, there will still be significant shortages of nursing labor in a handful of states, as well as most of the country’s rural areas. To solve this issue, providers need to recruit…
In the past, patient comfort often came at the cost of medical testing. However, the future of sleep monitoring doesn’t have to forgo either, with radar monitoring systems allowing for both a comfortable testing environment and a more accurate reading of sleep health. The post Redefining Sleep Health: From PSG Limitations to Next-Generation Solutions appeared…
To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs. The post Shifting Focus from Medication Costs to Medication Value appeared first on…
Herself Health and Blue Cross and Blue Shield of Minnesota have shifted away from a fee-for-service arrangement to a value-based arrangement. The post Blue Cross and Blue Shield of Minnesota, Herself Health Shift To VBC Contract appeared first on MedCity News.
KFF Health News contributor Phillip Reese discussed the rapid rise of breast cancer rates among Asian American and Pacific Islander women on KCBS Radio on Sept. 7. Click to hear Reese on KCBS. Read Reese’s “Breast Cancer Rises Among Asian American and Pacific Islander Women.” KFF Health News contributor Andy Miller discussed medical response to mass…
A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration. Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399),…
Bicara Therapeutics’ IPO raised $315 million raised for Phase 3 testing of a bifunctional antibody drug with potential to become a first-line treatment for head and neck cancers. Zenas BioPharma and MBX Biosciences also went public; all three companies upsized their IPOs. The post 3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology…
This week, longtime healthcare veterans Amy Abernethy and Brad Hirsch teamed up to launch Highlander Health — a Dallas-based startup focused on accelerating clinical evidence generation. The post Why Former FDA & Verily Exec Amy Abernethy Is Launching a New Venture appeared first on MedCity News.
This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.
Through a new partnership, students at schools within Cartwheel’s network in need of higher acuity care can access treatment through Charlie Health. The post Charlie Health Partners with Cartwheel to Address the Student Mental Health Crisis appeared first on MedCity News.